Biliary tract cancer: a retrospective study

Date 29 June 2016
Event ESMO World Congress on Gastrointestinal Cancer 2016
Session ESMO World Congress on Gastrointestinal Cancer 2016 - Abstracts book
Presenter A. Zemmour
Citation Annals of Oncology (2016) 27 (2): 86-101. 10.1093/annonc/mdw201
Authors A. Zemmour1, B. Larbaoui2, D. Yekrou3, Z. Boudinar Fatima2, K. Rekai4
  • 1Oncology Department Emir Abdelkader Oran, Oran, Algeria, /
  • 2Oncology Department, Oran, Algeria, /
  • 3Oncology Department, Sidi Belabes, Algeria, /
  • 4Medical Oncology, EHSO Emir Abdelkader, Oran, Algeria, /

Abstract

Biliary cancers are relatively rare, with about 3% of gastrointestinal cancers. This impact variable in the world, is increasing, especially for intrahepatic cholangiocarcinoma-carcinomas. These are most often sporadic or associated with chronic inflammatory diseases of the biliary tract. The presentation will be our experience in the management of cancers of the biliary tract in the Medical Oncology Department.